![Michael F. Haller](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael F.
Haller worked as VP-Alliance Management & Portfolio Development at Halozyme Therapeutics, Inc. He received an undergraduate and doctorate degree from The Johns Hopkins University and a graduate degree from Cornell University.
| Companies | Position | End |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 3 |
|---|---|
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Select your edition
All financial news and data tailored to specific country editions
